E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 6/30/2005 in the Prospect News PIPE Daily.

New Issue: NSP Pharma closes C$8.03 million private placement of stock

By Sheri Kasprzak

Atlanta, June 30 - NSP Pharma Corp. said it has closed three private placements for C$8.03 million.

The company sold a total of 3,030,190 shares at C$2.65 each.

Octagon Capital Corp. was the lead placement agent. First Canadian Capital Markets Ltd. was also a placement agent in the offering.

The company's chief executive officer, Sergio Martines, and its chairman, Vincenzo Guerrieri, purchased a total of 200,000 shares for proceeds of C$530,000.

Toronto-based NSP develops anti-aging skincare products. The proceeds will be used for new advertising campaigns, the development of new product lines, working capital and general corporate purposes.

Issuer:NSP Pharma Corp.
Issue:Stock
Amount:C$8.03 million
Shares:3,030,190
Price:C$2.65
Warrants:No
Placement agents:Octagon Capital Corp. (lead); First Canadian Capital Markets Ltd.
Settlement date:June 30
Stock price:C$3.85 at close June 30

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.